Focal semiologic and electroencephalographic features in patients with juvenile myoclonic epilepsy
Sixty patients regardless of age and gender diagnosed as Juvenile myoclonic epilepsy
by a Neurologist were included in this study.
Genetic mapping of a mayor susceptibility locus for juvenile myoclonic epilepsy
on chromosome 15q.
Somatosensory evoked potentials in juvenile myoclonic epilepsy
Mutations of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy
He cited as an example a 13-year-old girl who has a first generalized tonic-clonic seizure, a sister who has already been diagnosed with juvenile myoclonic epilepsy
, and an EEG trace that suggests JME.
This particular patient could have been suffering from three completely different epileptic syndromes, such as juvenile myoclonic epilepsy
(JME), frontal lobe epilepsy (FLE), or mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE).
Treatment of generalized tonic-clonic seizures and complex partial seizures - second line treatment for juvenile myoclonic epilepsy
About 10% of children with epilepsy never remit, including patients with juvenile myoclonic epilepsy
, reading epilepsy, myoclonic absence epilepsy, and early myoclonic encephalopathy.
Axel was diagnosed with primary juvenile myoclonic epilepsy
when he was 16.
In spite of the fact that in routine clinical practice, focal seizures may well be observed in generalized seizures and secondary generalized seizures are not infrequent in focal epilepsies (as the occurrence of automatisms or bilateral asymmetrical tonic seizures in juvenile myoclonic epilepsy
[JME]), the elimination of generalized/focal distinction, not for the epileptic seizures but for the epilepsies, has been widely criticized by several authors on the grounds that no sufficient scientific evidence was existent for such a radical change (11,12,13,14,15,16,17).
One of the most common epileptic syndromes is Juvenile Myoclonic Epilepsy
The Food and Drug Administration approved a new indication for Keppra (levetiracetam) as an adjunctive treatment for myoclonic seizures in adults and adolescents 12 years and older with juvenile myoclonic epilepsy